Kolkailah, Ahmed A. http://orcid.org/0000-0002-3327-1718
Riggs, Kayla
Navar, Ann Marie
Khera, Amit http://orcid.org/0000-0001-7255-6874
Article History
Accepted: 6 April 2022
First Online: 1 July 2022
Declarations
:
: Dr. Navar reports grant support from BMS, Esperion, and Janssen; and consulting for Amarin, Amgen, AstraZeneca, BI, Bayer, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, The Medicines Company, New Amsterdam, Cerner, 80Bio, and Pfizer. Dr. Navar also reports leadership or fiduciary role in the American Society for Preventive Cardiology, the National Forum, and JAMA Cardiology. Dr. Khera reports leadership or fiduciary role in the American Society for Preventive Cardiology Board. The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.